Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abigail Sloan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Statistical Methods in Medical Research|July 7, 2021
Statistical methods for analysis of combined biomarker data from multiple nested case-control studiesChao Cheng, Abigail Sloan, Molin Wang
Journal of Biopharmaceutical Statistics|February 9, 2024
Combination MCP-Mod for two-drug combination dose-ranging studiesYifan Zhou, Abigail Sloan, Sandeep Menon, et al.
Biostatistics (Oxford, England)|November 22, 2019
Statistical methods for biomarker data pooled from multiple nested case-control studiesAbigail Sloan, Stephanie A Smith-Warner, Regina G Ziegler, et al.
Biometrics|December 30, 2021
A repeated measures approach to pooled and calibrated biomarker dataAbigail Sloan, Chao Cheng, Bernard Rosner, et al.
The British Journal of Dermatology|November 8, 2023
An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligoAnindita Banerjee, Khaled Ezzedine, Ronald Shore, et al.
Statistics in Medicine|December 21, 2018
Design and analysis considerations for combining data from multiple biomarker studiesAbigail Sloan, Yue Song, Mitchell H Gail, et al.
Open Forum Infectious Diseases|January 9, 2026
Orolabial and Genital Herpes Clinical Trials: A Meta-analysis of EndpointsAbigail Sloan, Mahta Mortezavi, Jacqueline Gerhart, et al.
Clinical, Cosmetic and Investigational Dermatology|June 11, 2026
Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled StudyRohit Aggarwal, Elena Peeva, David Franklin Fiorentino, et al.
Scientific Reports|March 9, 2026
Ibuzatrelvir potently reduced viral RNA levels despite a high rate of anti-S seropositivity: a post hoc analysis of serology of the phase 2b studyJin Hyang Kim, Alex Knutson, Justin Smith, et al.
Archives of Dermatological Research|July 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligoYuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Statistical Methods in Medical Research|July 7, 2021
Statistical methods for analysis of combined biomarker data from multiple nested case-control studiesChao Cheng, Abigail Sloan, Molin Wang
Journal of Biopharmaceutical Statistics|February 9, 2024
Combination MCP-Mod for two-drug combination dose-ranging studiesYifan Zhou, Abigail Sloan, Sandeep Menon, et al.
Biostatistics (Oxford, England)|November 22, 2019
Statistical methods for biomarker data pooled from multiple nested case-control studiesAbigail Sloan, Stephanie A Smith-Warner, Regina G Ziegler, et al.
Biometrics|December 30, 2021
A repeated measures approach to pooled and calibrated biomarker dataAbigail Sloan, Chao Cheng, Bernard Rosner, et al.
The British Journal of Dermatology|November 8, 2023
An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligoAnindita Banerjee, Khaled Ezzedine, Ronald Shore, et al.
Statistics in Medicine|December 21, 2018
Design and analysis considerations for combining data from multiple biomarker studiesAbigail Sloan, Yue Song, Mitchell H Gail, et al.
Open Forum Infectious Diseases|January 9, 2026
Orolabial and Genital Herpes Clinical Trials: A Meta-analysis of EndpointsAbigail Sloan, Mahta Mortezavi, Jacqueline Gerhart, et al.
Clinical, Cosmetic and Investigational Dermatology|June 11, 2026
Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled StudyRohit Aggarwal, Elena Peeva, David Franklin Fiorentino, et al.
Scientific Reports|March 9, 2026
Ibuzatrelvir potently reduced viral RNA levels despite a high rate of anti-S seropositivity: a post hoc analysis of serology of the phase 2b studyJin Hyang Kim, Alex Knutson, Justin Smith, et al.
Archives of Dermatological Research|July 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligoYuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
Pageof 2